Bimergen Energy to Present Their $400 Million Growth Strategy at the Moody Capital Solutions 2026 Conference
Newport Beach CA, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Bimergen Energy (NYSE American: BESS), a U.S. energy infrastructure developer, owner and operator, is pleased to announce its participation at the upcoming Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference, taking place September 9-10, 2026, in New York City. Bob Brilon Co-CEO will be delivering an investor presentation and participating in scheduled 1-on-1 meetings with investors.
Date: Thursday, September 10, 2026
Time: 2:10 PM ET
Location: The Westin New York Grand Central, 212 E 42nd St, New York, NY
Presenter: Bob Brilon Co-CEO
More info: https://moodycapital.com/conference/
About the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference
The Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference brings together public and private growth companies, pioneering innovators, investors, C-suite executives and industry professionals across biotechnology, medical devices, pharmaceuticals, healthcare technology and other growth industries. The two-day conference features company presentations, one-on-one investor meetings, fireside chats, capital markets and financing panels, and networking opportunities with institutional investors and family offices.
About Bimergen Energy
Bimergen Energy Corporation (NYSE American: BESS) is a US- based renewable energy developer, asset owner and operator focused on utility-scale battery energy storage system (BESS) projects. The operating revenue generation comes from buying energy at lower off-peak prices and selling them back to the same grid at higher peak prices. www.Bimergen.com
For additional Information, please contact:
Contact:
RedChip Companies Inc.
1-407-644-4256 | 1-800-REDCHIP (733-2447)
BESS@redchip.com

The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular

5 Stocks to Buy After Earnings

The 10 Best Dividend Stocks

7 Undervalued Stocks That Crushed Earnings

2 5-Star Stocks to Buy at Big Discounts


